LoginRegister

    Bristol-Myers to get negative CHMP opinion on renal cancer drugs

    Written by Ruby Khatun Khatun   |  
    Bristol-Myers to get negative CHMP opinion on renal cancer drugs

    NEW YORK: Bristol-Myers Squibb Co said it was told by European regulators that they will recommend against approving the company’s drugs Opdivo and Yervoy to treat first-line renal cancer.


    The company said it was notified on Wednesday that would be receiving a negative opinion from the Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency.


    “We strongly disagree with this opinion. And in the interest of patients, we will pursue a reexamination,” Bristol-Myers CEO Giovanni Caforio said on a conference call to discuss the company’s second quarter earnings.





    (Reporting by Michael Erman; Editing by Chizu Nomiyama)




    Bristol-MyersBristol-Myers SquibbCHMP opinionCommittee for Medicinal Products for Human UseEuropean Medicines AgencyGiovanni CaforionegativeOpdivorenal cancerrenal cancer drugsYervoy
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X